


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
INO
Inovio Pharma
$1.69
Strengths

Upgraded on attractively valued
INO Price Performance
$2.07 (-18.36%)
$2.56 (-33.98%)
$1.49 (+13.42%)
$2.2 (-23.18%)
INO has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

INO overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
INO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
INO Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels
What is INO current stock price?
What are INO stock strengths?
What is INO Risk Level?
What is INO market cap and volume?
What is INO current Stock IQ?
Should I buy INO stock right now?
Is INO a Strong Buy right now?
What does a 'Strong Buy' rating mean for INO?
What does a 'Strong Sell' rating mean for INO?
What factors influence INO's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+4.89%
+0.30%
-1.43%
+0.96%
+15.95%
INO
Inovio Pharma
Current Price
$1.69
Stock Insights
Strengths

Upgraded on attractively valued

INO Price Performance
$2.07 (-18.36%)
$2.56 (-33.98%)
$1.49 (+13.42%)
$2.2 (-23.18%)
INO Analysts Opinion
INO Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future
![]()
INO Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
INO Street Sentiment is bullish and have negative views on the near-term outlook
INO has Extreme risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Price under $5

High volatilty

Average key support and resistance price levels
INO Stock IQ
INO Latest Analysis
Inovio drops as respiratory papillomatosis asset denied accelerated review.
Mon Dec 29, 2025
Inovio Stock Sinks As FDA Pushes Back On Accelerated Approval For Rare Disease Drug. ) stock fell Monday after the United States Food and Drug Administration accepted the company’.s Biologics License Application (BLA) for INO-3107 but raised concerns tied to the .The biotechnology company focused on developing and commercializing DNA medicines said that the FDA accepted the company’.sBLA for INO-3107 for review as a potential treatment for adults with Recurrent Respiratory Papillomatos
Mon Dec 29, 2025
FDA Accepts INOVIOs BLA For INO-3107 In Recurrent Respiratory Papillomatosis . (RTTNews) - Inovio Pharmaceuticals Inc. (INO) announced that its Biologics License Application for INO-3107 proposed for the treatment of adults with recurrent respiratory papillomatosis has been accepted for review by the FDA.
Mon Dec 29, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.